Adult ADHD Digital Biomarker Feasibility Assessment: Charité Universitätsmedizin Berlin
Fuente:
Zenodo
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Recurso digital |
| Sprache: | Englisch |
| Veröffentlicht: |
Zenodo
2026
|
| Schlagworte: | |
| Online-Zugang: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1866901665276231680 |
|---|---|
| author | Koroma, Martha Wuya |
| author_facet | Koroma, Martha Wuya |
| contents | <p>There is no validated digital endpoint for adult ADHD in Europe. This document is a Phase II site feasibility assessment for a digital biomarker-aided diagnostic protocol at Charité Universitätsmedizin Berlin, targeting adult women with suspected or unrecognised ADHD and West African heritage. The proposed battery spans three evidence tiers: actigraphy and rest-activity rhythm (established, adult validation gap), continuous performance testing (validated, existing Charité infrastructure), and smartphone passive monitoring (novel, pilot-stage with large effect sizes). The framework includes community-anchored site feasibility, GDPR Article 9 privacy-by-design architecture, and EU MDR Class IIa regulatory pathway analysis.</p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_20270533 |
| institution | Zenodo |
| language | eng |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | Adult ADHD Digital Biomarker Feasibility Assessment: Charité Universitätsmedizin Berlin Koroma, Martha Wuya Digital Biomarker ADHD Actigraphy Smartphone/statistics & numerical data Site Feasibility Neurodevelopmental Disorders GDPR Charité Berlin <p>There is no validated digital endpoint for adult ADHD in Europe. This document is a Phase II site feasibility assessment for a digital biomarker-aided diagnostic protocol at Charité Universitätsmedizin Berlin, targeting adult women with suspected or unrecognised ADHD and West African heritage. The proposed battery spans three evidence tiers: actigraphy and rest-activity rhythm (established, adult validation gap), continuous performance testing (validated, existing Charité infrastructure), and smartphone passive monitoring (novel, pilot-stage with large effect sizes). The framework includes community-anchored site feasibility, GDPR Article 9 privacy-by-design architecture, and EU MDR Class IIa regulatory pathway analysis.</p> |
| title | Adult ADHD Digital Biomarker Feasibility Assessment: Charité Universitätsmedizin Berlin |
| topic | Digital Biomarker ADHD Actigraphy Smartphone/statistics & numerical data Site Feasibility Neurodevelopmental Disorders GDPR Charité Berlin |
| url | https://doi.org/10.5281/zenodo.20270533 |